416 related articles for article (PubMed ID: 17715395)
1. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer.
Tan PK; Wang J; Littler PL; Wong KK; Sweetnam TA; Keefe W; Nash NR; Reding EC; Piu F; Brann MR; Schiffer HH
Mol Pharmacol; 2007 Dec; 72(6):1440-6. PubMed ID: 17715395
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer.
Schiffer HH; Reding EC; Fuhs SR; Lu Q; Piu F; Wong S; Littler PL; Weiner DM; Keefe W; Tan PK; Nash NR; Knapp AE; Olsson R; Brann MR
Mol Pharmacol; 2007 Feb; 71(2):508-18. PubMed ID: 16968809
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
Blanquart C; Boute N; Lacasa D; Issad T
Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the insulin receptor and Grb14: a dynamic study in living cells using BRET.
Nouaille S; Blanquart C; Zilberfarb V; Boute N; Perdereau D; Burnol AF; Issad T
Biochem Pharmacol; 2006 Nov; 72(11):1355-66. PubMed ID: 16934761
[TBL] [Abstract][Full Text] [Related]
5. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer.
Blanquart C; Gonzalez-Yanes C; Issad T
Mol Pharmacol; 2006 Nov; 70(5):1802-11. PubMed ID: 16926280
[TBL] [Abstract][Full Text] [Related]
7. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
Prinz A; Diskar M; Erlbruch A; Herberg FW
Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
[TBL] [Abstract][Full Text] [Related]
8. Real-time measurement in living cells of insulin-like growth factor activity using bioluminescence resonance energy transfer.
Laursen LS; Oxvig C
Biochem Pharmacol; 2005 Jun; 69(12):1723-32. PubMed ID: 15935147
[TBL] [Abstract][Full Text] [Related]
9. Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation.
De Vries L; Finana F; Cachoux F; Vacher B; Sokoloff P; Cussac D
Cell Signal; 2010 Jan; 22(1):158-65. PubMed ID: 19781635
[TBL] [Abstract][Full Text] [Related]
10. Assays to measure the activation of membrane tyrosine kinase receptors: focus on cellular methods.
Minor LK
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):760-5. PubMed ID: 14579525
[TBL] [Abstract][Full Text] [Related]
11. Characterization of G-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transfer.
Jorgensen R; Holliday ND; Hansen JL; Vrecl M; Heding A; Schwartz TW; Elling CE
Mol Pharmacol; 2008 Feb; 73(2):349-58. PubMed ID: 17986524
[TBL] [Abstract][Full Text] [Related]
12. Detecting and imaging protein-protein interactions during G protein-mediated signal transduction in vivo and in situ by using fluorescence-based techniques.
Hébert TE; Galés C; Rebois RV
Cell Biochem Biophys; 2006; 45(1):85-109. PubMed ID: 16679566
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
Eberle A; Reinehr R; Becker S; Häussinger D
Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
[TBL] [Abstract][Full Text] [Related]
14. Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET).
Kim YP; Jin Z; Kim E; Park S; Oh YH; Kim HS
Biochem Biophys Res Commun; 2009 May; 382(3):530-4. PubMed ID: 19289109
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase receptors as attractive targets of cancer therapy.
Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.
Perrone F; Jocollè G; Pennati M; Deraco M; Baratti D; Brich S; Orsenigo M; Tarantino E; De Marco C; Bertan C; Cabras A; Bertulli R; Pierotti MA; Zaffaroni N; Pilotti S
Eur J Cancer; 2010 Oct; 46(15):2837-48. PubMed ID: 20692828
[TBL] [Abstract][Full Text] [Related]
17. Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms.
Ozaki K; Miyazaki S; Tanimura S; Kohno M
J Cell Sci; 2005 Dec; 118(Pt 24):5861-71. PubMed ID: 16339969
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.
Boute N; Pernet K; Issad T
Mol Pharmacol; 2001 Oct; 60(4):640-5. PubMed ID: 11562424
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase inhibitors.
Haluska P; Adjei AA
Curr Opin Investig Drugs; 2001 Feb; 2(2):280-6. PubMed ID: 11816845
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma.
Fasig JH; Dupont WD; LaFleur BJ; Olson SJ; Cates JM
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):95-104. PubMed ID: 17973908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
